Literature DB >> 19855995

Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology.

Mélanie Métrich1, Magali Berthouze, Eric Morel, Bertrand Crozatier, Ana Maria Gomez, Frank Lezoualc'h.   

Abstract

Exchange proteins directly activated by cyclic AMP (Epac) were discovered 10 years ago as new sensors for the second messenger cyclic AMP (cAMP). Epac family, including Epac1 and Epac2, are guanine nucleotide exchange factors for the Ras-like small GTPases Rap1 and Rap2 and function independently of protein kinase A. Given the importance of cAMP in the cardiovascular system, numerous molecular and cellular studies using specific Epac agonists have analyzed the role and the regulation of Epac proteins in cardiovascular physiology and pathophysiology. The specific functions of Epac proteins may depend upon their microcellular environments as well as their expression and localization. This review discusses recent data showing the involvement of Epac in vascular cell migration, endothelial permeability, and inflammation through specific signaling pathways. In addition, we present evidence that Epac regulates the activity of various cellular compartments of the cardiac myocyte and influences calcium handling and excitation-contraction coupling. The potential role of Epac in cardiovascular disorders such as cardiac hypertrophy and remodeling is also discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19855995     DOI: 10.1007/s00424-009-0747-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  103 in total

1.  Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs.

Authors:  J de Rooij; H Rehmann; M van Triest; R H Cool; A Wittinghofer; J L Bos
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

2.  Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels.

Authors:  Gregor I Purves; Tomoko Kamishima; Lowri M Davies; John M Quayle; Caroline Dart
Journal:  J Physiol       Date:  2009-07-15       Impact factor: 5.182

Review 3.  Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.

Authors:  Rodolphe Fischmeister; Liliana R V Castro; Aniella Abi-Gerges; Francesca Rochais; Jonas Jurevicius; Jérôme Leroy; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2006-10-13       Impact factor: 17.367

4.  cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells.

Authors:  Guoxin Kang; Oleg G Chepurny; Brian Malester; Michael J Rindler; Holger Rehmann; Johannes L Bos; Frank Schwede; William A Coetzee; George G Holz
Journal:  J Physiol       Date:  2006-04-13       Impact factor: 5.182

5.  Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II.

Authors:  Emily A Oestreich; Sundeep Malik; Sanjeewa A Goonasekera; Burns C Blaxall; Grant G Kelley; Robert T Dirksen; Alan V Smrcka
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes.

Authors:  Mickaël Derangeon; Nicolas Bourmeyster; Isabelle Plaisance; Caroline Pinet-Charvet; Qian Chen; Fabien Duthe; Michel R Popoff; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

7.  Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.

Authors:  Seung Namkoong; Chun-Ki Kim; Young-Lai Cho; Ji-Hee Kim; Hansoo Lee; Kwon-Soo Ha; Jongseon Choe; Pyeung-Hyeun Kim; Moo-Ho Won; Young-Geun Kwon; Eun Bo Shim; Young-Myeong Kim
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

8.  The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.

Authors:  Utako Yokoyama; Hemal H Patel; N Chin Lai; Nakon Aroonsakool; David M Roth; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

9.  Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy.

Authors:  Coskun Ulucan; Xu Wang; Erdene Baljinnyam; Yunzhe Bai; Satoshi Okumura; Motohiko Sato; Susumu Minamisawa; Shinichi Hirotani; Yoshihiro Ishikawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-08       Impact factor: 4.733

10.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

View more
  33 in total

1.  Opposing HDAC4 nuclear fluxes due to phosphorylation by β-adrenergic activated protein kinase A or by activity or Epac activated CaMKII in skeletal muscle fibres.

Authors:  Yewei Liu; Martin F Schneider
Journal:  J Physiol       Date:  2013-05-07       Impact factor: 5.182

2.  Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells.

Authors:  Bernadette Chen; Andrea E Calvert; Xiaomei Meng; Leif D Nelin
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-23       Impact factor: 6.914

Review 3.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

Review 4.  Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.

Authors:  Manuel Morgado; Elisa Cairrão; António José Santos-Silva; Ignacio Verde
Journal:  Cell Mol Life Sci       Date:  2011-09-27       Impact factor: 9.261

5.  Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis.

Authors:  Xi He; Aleksandra Drelich; Shangyi Yu; Qing Chang; Dejun Gong; Yixuan Zhou; Yue Qu; Yang Yuan; Zhengchen Su; Yuan Qiu; Shao-Jun Tang; Angelo Gaitas; Thomas Ksiazek; Zhiyun Xu; Jia Zhou; Zongdi Feng; Maki Wakamiya; Fanglin Lu; Bin Gong
Journal:  Life Sci       Date:  2019-02-07       Impact factor: 5.037

6.  Epac enhances excitation-transcription coupling in cardiac myocytes.

Authors:  Laetitia Pereira; Gema Ruiz-Hurtado; Eric Morel; Anne-Coline Laurent; Mélanie Métrich; Alejandro Domínguez-Rodríguez; Sandra Lauton-Santos; Alexandre Lucas; Jean-Pierre Benitah; Donald M Bers; Frank Lezoualc'h; Ana M Gómez
Journal:  J Mol Cell Cardiol       Date:  2011-10-29       Impact factor: 5.000

7.  β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts.

Authors:  Chao Chen; Jianhai Du; Wei Feng; Yao Song; Zhizhen Lu; Ming Xu; Zijian Li; Youyi Zhang
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

8.  Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

9.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

10.  A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.

Authors:  Muayad Almahariq; Tamara Tsalkova; Fang C Mei; Haijun Chen; Jia Zhou; Sarita K Sastry; Frank Schwede; Xiaodong Cheng
Journal:  Mol Pharmacol       Date:  2012-10-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.